key: cord-1047798-frxbl8ys authors: Schwabenland, Marius; Salié, Henrike; Tanevski, Jovan; Killmer, Saskia; Lago, Marilyn Salvat; Schlaak, Alexandra Emilia; Mayer, Lena; Matschke, Jakob; Püschel, Klaus; Fitzek, Antonia; Ondruschka, Ben; Mei, Henrik E.; Boettler, Tobias; Neumann-Haefelin, Christoph; Hofmann, Maike; Breithaupt, Angele; Genc, Nafiye; Stadelmann, Christine; Saez-Rodriguez, Julio; Bronsert, Peter; Knobeloch, Klaus-Peter; Blank, Thomas; Thimme, Robert; Glatzel, Markus; Prinz, Marco; Bengsch, Bertram title: Deep spatial profiling of human COVID-19 brains reveals neuroinflammation with distinct microanatomical microglia-T cell interactions date: 2021-06-09 journal: Immunity DOI: 10.1016/j.immuni.2021.06.002 sha: d4b5ac0ba46dd8f87e36793003aee92c26a77d28 doc_id: 1047798 cord_uid: frxbl8ys COVID-19 can cause severe neurological symptoms, but the underlying pathophysiological mechanisms are unclear. Here, we interrogated the brain stem and olfactory bulb in COVID-19 patients postmortem using imaging mass cytometry to understand the local immune response at a spatially resolved, high-dimensional single-cell level and compared their immune map to non-COVID respiratory failure, multiple sclerosis and control patients. We observed substantial immune activation in the central nervous system with pronounced neuropathology (astrocytosis, axonal damage, blood-brain-barrier leakage) and detected viral antigen in ACE2 receptor-positive cells enriched in the vascular compartment. Microglial nodules and the perivascular compartment represented COVID-19-specific microanatomic immune niches with context-specific cellular interactions enriched for activated CD8+ T cells. Altered brain T cell–microglial interactions were linked to clinical measures of systemic inflammation and disturbed hemostasis. This study identifies profound neuroinflammation with activation of innate and adaptive immune cells as correlates of COVID-19 neuropathology, with implications for potential therapeutic strategies. COVID-19 due to SARS-CoV-2 is a multifaceted disease with multi-organ complications. Major 22 complications include neurological symptoms that can occur during acute infection in up to 67 % 23 of patients, but can also persist or even emerge after viral elimination (Helms et al., 2020; Mao 24 et al., 2020; Varatharaj et al., 2020) . A characteristic neurological symptom of COVID-19 is 25 anosmia (the loss of the sense of smell) but neurological symptoms range from headache, 26 fatigue, memory impairment, vomiting and gait disorders to breathing difficulties and coma, 27 suggesting involvement of several brain regions such as the olfactory bulb but also infratentorial 28 regions like the medulla (Ellul et al., 2020) . Thromboembolic events including stroke were 29 reported to be a complication of COVID-19, but are unlikely to explain COVID-19 neurological 30 symptoms in the majority of cases. A recent report further points to microvascular pathology in 31 COVID-19 brains (Lee et al., 2021) . A possible central nervous system (CNS) entry mechanism 32 described is olfactory transmucosal SARS-CoV-2 invasion that may give access to the olfactory 33 bulb (Cantuti-Castelvetri et al., 2020; Meinhardt et al., 2020), but neuroinvasion into cortical 34 neurons has also been described (Song et al., 2021) . SARS-CoV-2 has been detected in some 35 Subclustering of CD8 T cell cluster c19 revealed further heterogeneity among CD8 T cells, as 258 expected based on the differential T cell activation patterns tied to microanatomic sites. We 259 identified 12 CD8 subclusters, among which a CD8 subcluster (sc_c12) that was dominant in We wondered if patterns of COVID-19 neuroinflammation differed from patients with severe 300 history of respiratory failure and ECMO therapy or patients with MS. Indeed, we observed major 301 differences in cellular immune subsets between COVID-19 patients and ECMO or MS patients 302 patients illustrated earlier (Figures 2-4) . Other notable differences include astrocyte clusters 311 c12 and c22 that were enriched in COVID-19 ( Figure 6A ). In sum, these analyses illustrate 312 J o u r n a l P r e -p r o o f 15 specific COVID-19 immune infiltration patterns that highlight the role of the perivascular immune 313 compartment and point to significant differences in microglial, myeloid and T cell clusters in 314 comparison to ECMO and MS disease controls. 315 We had initially focused our analysis on the brain stem due to significant immune cell infiltration 318 Figure 6B) . In our cohort, we 327 observed reduced microglial nodule formation in the olfactory bulb compared to the brain stem, 328 both by IMC and additional IHC analysis that covered larger brain areas (Supplementary 329 Figure 6C ). Additional differences in cell subtypes were found for astrocytic clusters -while 330 cluster c12 cells were primarily found in the medulla, cluster c22 cells enriched in the olfactory 331 bulb (Supplementary Figure 6B) . Cluster c22 had higher per-cell protein expression of GFAP 332 in line with reactive astrogliosis in the olfactory bulb and also displayed higher ACE2 expression 333 Finally, we asked if the observed neuroinflammatory changes observed in the patients' brain 364 tissue by our deep spatial profiling were linked to their clinical data ( Figure 7F ). There was a 365 positive correlation between CD8 cluster c19 counts and serum C-reactive protein (CRP) In sum, these analyses highlight the vascular compartment as a key site of immune activation 376 and virus detection in COVID-19 brains. Our analysis provide a framework for understanding the 377 neurological comorbidities of SARS-CoV-2-infection, highlight specific cellular brain immune 378 clusters involved in a COVID-19-specific neuroinflammatory pattern and can help identify 379 targets for immune intervention. 380 Here, by performing highly multiplexed spatial analysis of the cellular composition and 382 immunological phenotype of CNS tissue from patients that died with COVID-19, we identified a 383 profound immune activation dominated by specific CD8 T cell clusters affecting (1) the 384 vasculature and (2) significant CD8 T cell -microglial crosstalk in the parenchyma that 385 frequently manifests in the formation of microglial nodules. Virus protein could be identified in 386 vascular brain structures providing a possible foundation for the broad immune activation 387 observed. The degree of neuroinflammation was variable but major changes in microglial 388 immune activation were observed in about 80 % of patients. This immune infiltration was 389 associated with considerable axonal and vascular pathology. This severe neuroinflammation 390 with profound neuronal damage in COVID-19 patients might explain the high prevalence of 391 transitory and long-lasting neurological comorbidities in SARS-CoV-2 infection. 392 Key findings of our study are the broad immune activation and anatomical compartmentalization 393 of the altered brain immune responses in COVID-19 patients. Perivascular immune activation 394 and infiltration by distinct CD8 and CD4 T cell clusters and expansion of disease-associated 395 clusters of perivascular macrophages and microglial cells was a dominant feature found in the 396 majority of patients. Our analyses also revealed compartmentalized changes in brain immunity. 397 In particular, the perivascular immune infiltrate differed quantitatively and qualitatively from the 398 parenchymal and microglial nodule immune response and was associated with increased 399 vascular leakage as an indication of compromised BBB. This microvascular injury is in line with 400 a recent report of compromised vascular integrity in COVID-19 patients (Lee et al., 2021) . In our study, we tested for the expression of multiple targetable immune checkpoints, against Perivascular leakage fitting to microvascular injury and compromised BBB was prominent in our 433 cohort studied. However, our results were unexpected in light of earlier assessments that mainly 434 reported hypoxic changes and thromboembolic events and did not report significant encephalitis 435 (Solomon et al., 2020) . Of note, only 16 % of the patients in our cohort had thromboembolic 436 events that occured in distant brain regions, suggesting that the profound neuroinflammation 437 observed in the brain stem and olfactory bulb and the thromboembolic events are unrelated. 438 Moreover, even when those samples were excluded from our studies, similar conclusions were 439 reached (data not shown). The high prevalence of neuroinflammation during COVID-19 440 observed in our work highlights the need for better strategies targeting or preventing this 441 inflammatory encephalitis. 442 Our study underlines the relevance of high-parametric deeply resolved spatial analysis of brain 443 immunity that is able to dissect the brain's immune populations, such as distinct microglial 444 clusters, and multiple brain compartments in order to understand the immunological and 445 pathophysiological changes during COVID-19. The identification of the disease-linked CD8 T 446 cell-microglial crosstalk that occurred in specific anatomical compartments and between defined 447 cellular clusters that involve multiple immune checkpoints highlights possible cellular and 448 molecular targets for therapeutic intervention. 449 This work is based on postmortem tissue samples obtained during the first wave of the COVID-451 19 pandemic in Germany. The broad neuroinflammation observed by deep spatial immune 452 analysis in this study informs about the CNS manifestation of COVID-19 and fit to the high rate 453 of neurologic symptoms during COVID-19 (Ellul et al., 2020) . Since only patients who 454 succumbed to disease which did not have prospective complete neurological assessment could 455 be analyzed, however, it remains to be determined if the neuroinflammation observed in this 456 study is also linked to specific neurological symptoms or if they are also present in patients with 457 neurological symptoms that recover. 458 The use of autopsy tissue samples in this study precluded functional studies, which would be 459 See also Figure S1 . See also Figure S4 . E: A total of 9 different tests for viral protein or RNA were performed in the brains of COVID-19 patients. Results are shown in the heatmap (positive -red, negative -blue, gay -test was not performed). Requests for further information resources, reagents and code should be directed to and will be fulfilled 634 by the lead contact, Bertram Bengsch (bertram.bengsch@uniklinik-freiburg.de). 635 This study did not generate any new unique reagents. 637 and placed in xylene. Vitro-Clud® served as mounting medium for coverslips. Bielschowsky silver 724 impregnation was conducted as follows: after deparaffinization in Xylene, the slides were incubated in a 725 20% silver nitrate solution for 20 minutes. Thereafter, the slides were transferred to distilled water. 32% 726 ammonia solution was added dropwise to the silver nitrate solution until the precipitates had dissolved. 727 Two more drops were added. The sections were incubated in this solution for 15 minutes in the dark. 728 After rinsing the specimens in 100 ml distilled water with 3 drops of 32% ammonia solution, 10 drops of 729 developer solution were added to the silver nitrate solution. The developer solution was obtained by 730 diluting 20 ml of 37% formaldehyde solution in 100 ml distilled water, supplemented with 0.5 g citric 731 acid and 2 drops 65% nitric acid. The reaction was stopped by washing the slides in water, followed by a 732 2 minute incubation in a 2 % sodium thiosulphate solution. After counterstaining with Gill's Hematoxylin 733 solution, Vitro-Clud® was used as mounting medium. 734 A 38-marker IMC panel was designed including markers for the adaptive and innate immune system as 736 well as brain-specific cell populations and stained in 25 COVID-19 patients and 5 control patients 737 (Supplementary table 2 laser-ablated spot-by-spot at 200 Hz resulting in a pixel size/resolution of 1 µm². Preprocessing of the 764 raw data was conducted using the CyTOF software v7.0. Image acquisition control was performed using 765 MCD Viewer v1.0.560.6. A 1500 µm² image per medulla or olfactory bulb section was acquired using a 766 Hyperion Imaging System (Fluidigm). Due to small tissue sections in some olfactory bulb sections, 767 multiple ROIs were obtained for those samples and data was analyzed after area normalization. 768 Tissue from a deceased patient with COVID-19 pneumonia and invasive ventilation was obtained 790 postmortem. Immunohistochemistry for Iba1 revealed many microglia nodules within the medulla of 791 this patient. Tissues were manually dissociated and filtered using a 40µm cell strainer. Mononuclear 792 cells were isolated using density gradient centrifugation. Viable cells were counted and stained for mass 793 cytometry. Mass cytometry reagents were obtained or generated by custom conjugation to isotope-794 loaded polymers using the Maxpar X8 antibody labelling kit. Mass cytometry antibodies used are shown 795 in Supplementary table 3. Staining was performed after β2-microglobulin-based sample barcoding. 796 Briefly, single-cell suspensions were pelleted, incubated with 20 μM Lanthanum-139-loaded maleimido-797 mono-amine-DOTA in PBS for 10min at RT for live/dead discrimination (LD). Cells were washed in 798 staining buffer and resuspended in surface antibody cocktail, incubated for 30min at RT, washed twice in 799 staining buffer, fixed and permeabilized using FoxP3 staining buffer set, and stained intracellularly for 800 60min at RT. Cells were further washed twice before fixation in 1.6% PFA solution containing 125nM 801 Iridium overnight at 4°C. Prior to data acquisition on CyTOF Helios (Fluidigm), cells were washed twice in 802 PBS and once in cell acquisition solution. 803 Non-transformed data was normalized to 99th percentile for Phenograph clustering algorithm 805 implemented in histoCAT that can identify even rare clusters of cells with distinct marker expression. 806 Clustering was performed based on data from channels containing lineage and activation markers: Arg- correlations between clinical and high-dimensional data of patients in figure 7F was conducted in R 842 studio using corrplot and RColorBrewer packages. 843 Clusters were gated on patients and counts were exported from OMIQ. The cluster composition 845 between patient groups was visualized using the ggplot2 stacked bar graph function in R studio. 846 Spatial cellular interaction patterns were tested by neighborhood analysis as implemented in histoCAT. 848 Briefly, it was examined per image whether a cell of a certain Phenograph cluster was located 849 significantly (p < 0.05) more frequently in close proximity (4 pixel) to a cell of another cell cluster than 850 expected by a random distribution of cells. The results for each cluster pair were summarized and 851 visualized in a heatmap using R studio Pheatmap package. Rows represent the neighborhood of a cell 852 phenotype of interest whereas columns indicate the enrichment or depletion of a cell in other 853 neighborhoods. 854 Distance to vasculature was assessed for all cluster c19 cells and a violin plot was generated using 856 GraphPad Prism 8. Based on the calculations of the vascular proximity map, a random distribution of 857 cells was generated by plotting the distances of all pixels of the images. 858 FIJI, a distribution of ImageJ, was used for the calculation of the proximity of each pixel to the closest 860 collagen-or CD34-positive structure above background threshold. The values for all 2.25 million pixels 861 per image were obtained and plotted with ggplot2 function in R studio. 862 The calculation of the microglia nodule index map was performed in a similar way to the vascular 864 proximity map. The starting point was the signal in the 141Pr-Iba1 channel. The 141Pr-Iba1-positive 865 pixels were measured in a radius of 15 µm and put in relation to the total area. The values were 866 calculated for all 2.25 million pixels in the image. The map was again visualized using ggplot2 in R studio. 867 The composition of the cohort was visualized based on the criteria of microgliosis (moderate 869 microgliosis with > 80 microglia cells per mm 2 and severe microgliosis > 160 cells per mm 2 ) and the 870 presence or absence of microglia nodules. 871 Distances to vasculature inferred by distance to nearest collagen-or CD34-expressing pixel and 873 microglia nodule index were used to identify 4 compartments: Microglia nodules (nodule index ≥ 0.5), 874 perivascular (nodule index < 0.5, distance to vasculature < 5 µm), juxtavascular (nodule index < 0.5, 875 distance to collagen-I ≥ 5 µm and ≤ 20 µm), parenchymal (nodule index < 0.5, distance to collagen-I > 20 876 µm). 877 analyzed by Wilcoxon signed-rank tests. Differences in cluster counts between COVID-19, ECMO and MS 902 patients in figure 6A were determined by ordinary one-way ANOVA tests for each cluster. Further 903 statistical details for each plot can be found in the corresponding figure legend. 904 For the correlations between clinical and high-dimensional data shown as a matrix in figure 7F the 905 pairwise correlation was determined using spearman tests and the significance of the correlation was 906 determined by fisher's exact test using ggplot2, tidyverse, ggpubr, forcats, dplyr and janitor packages. 907 Correlations between CRP, Quick and aPTT with c19 cell count in supplementary figure 7C-E were 908 determined using the ggscatter function of the ggpubr package in R studio. 909 Throughout the manuscript * indicates p < 0.05, ** p < 0.01, *** p < 0.001 and **** p < 0.0001. COVID-19 can cause severe neurological symptoms. By deep spatial analysis of postmortem brain tissue, Schwabenland, Salie et al. identify accumulation of distinct microglial and T cell subsets in microglial nodules and the perivasculature. They observe neuroinflammation with axonal damage, virus-associated perivascular inflammation and compromised blood-brain-barrier. This profound neuroinflammation highlights the need for better strategies against this COVID-19 CNS manifestation. • Performed detailed molecular and spatial analysis of the COVID-19 brain immune response Cluster 4 Cluster 5 Cluster 6 Cluster 7 Cluster 8 Cluster 9 Cluster 10 Cluster 11 Cluster 12 Cluster 13 Cluster 14 Cluster 15 Cluster 16 Cluster 17 Cluster 18 Cluster 19 Cluster 20 Cluster 21 Cluster 22 Cluster 23 Cluster 24 Cluster 25 Cluster 26 Cluster 27 Cluster 28 Cluster 30 Cluster 31 Cluster 34 Cluster 33 Cluster 32 Cluster 29 Cluster 4 Cluster 5 Cluster 6 Cluster 7 Cluster 8 Cluster 9 Cluster 10 Cluster 11 Cluster 12 Cluster 13 Cluster 14 Cluster 15 Cluster 16 Cluster 17 Cluster 18 Cluster 19 Cluster 20 Cluster 21 Cluster 22 Cluster 23 Cluster 24 Cluster 25 Cluster 26 Cluster 27 Cluster 28 Cluster 30 Cluster 31 Cluster 34 Cluster 33 Cluster 32 Cluster 29 Cluster 34 Cluster 33 Cluster 32 Cluster 31 Cluster 30 Cluster 29 Cluster 28 Cluster 27 Cluster 26 Cluster 25 Cluster 24 Cluster 23 Cluster 22 Cluster 21 Cluster 20 Cluster 19 Cluster 18 Cluster 17 Cluster 16 Cluster 15 Cluster 14 Cluster 13 Cluster 12 Cluster 11 Cluster 10 Cluster 9 Cluster 8 Cluster 7 Cluster 6 Cluster 5 Cluster 4 Cluster 3 Cluster 1 Cluster 3 Cluster 4 Cluster 5 Cluster 6 Cluster 7 Cluster 8 Cluster 9 Cluster 10 Cluster 11 Cluster 12 Cluster 13 Cluster 14 Cluster 15 Cluster 16 Cluster 17 Cluster 18 Cluster 19 Cluster 20 Cluster 21 Cluster 22 Cluster 23 Cluster 24 Cluster 25 Cluster 26 Cluster 27 Cluster 28 Cluster 30 Cluster 31 Cluster 34 Cluster 33 Cluster 32 Cluster 29 PD-1 Data S1 J o u r n a l P r e -p r o o f Epigenomic-Guided Mass Cytometry Profiling 918 Reveals Disease-Specific Features of Exhausted CD8 T Cells ilastik: interactive machine learning for (bio)image analysis Neuropilin-1 facilitates SARS-CoV-2 924 cell entry and infectivity Neurological associations of COVID-19 Neurologic Features in Severe SARS-929 CoV-2 Infection Neurological Manifestations Neuropathologic features 936 of four autopsied COVID-19 patients Comprehensive mapping of 939 immune perturbations associated with severe COVID-19 Microvascular Injury in the Brains of Patients with Covid-19 Data-Driven Phenotypic Dissection of 945 AML Reveals Progenitor-like Cells that Correlate with Prognosis Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease Deep immune profiling of 951 COVID-19 patients reveals distinct immunotypes with therapeutic implications Neuropathology of patients with 954 COVID-19 in Germany: a post-mortem case series CellProfiler 3.0: Next-generation image 957 processing for biology Early activation of microglia in the 959 pathogenesis of fatal murine cerebral malaria Platinum-conjugated antibodies for 961 application in mass cytometry Olfactory transmucosal SARS-CoV-2 invasion as a port 964 of central nervous system entry in individuals with COVID-19 Microglia and Central Nervous 966 System-Associated Macrophages-From Origin to Disease Modulation The role of peripheral immune cells in the CNS in steady state 968 and disease Multiorgan and Renal Tropism of 971 SARS-CoV-2 Neuropathology of COVID-19: a spectrum of vascular and acute disseminated 974 encephalomyelitis (ADEM)-like pathology PD-1-Expressing SARS-CoV-2-Specific CD8(+) T Cells Are Not 977 Exhausted, but Functional in Patients with COVID-19 Postmortem Examination of Patients With COVID-19 histoCAT: analysis of cell 982 phenotypes and interactions in multiplex image cytometry data Characterization of pre-existing and induced SARS-985 CoV-2-specific CD8(+) T cells Robust T Cell Immunity in 988 Convalescent Individuals with Asymptomatic or Mild COVID-19 Neuropathological Features of Covid-19 Neuroinvasion of SARS-CoV-2 in human and mouse brain A new fate mapping system reveals context-997 dependent random or clonal expansion of microglia Microglial nodules provide the environment 1000 for pathogenic T cells in human encephalitis Neurological and neuropsychiatric complications 1003 of COVID-19 in 153 patients: a UK-wide surveillance study Early evidence of 1005 pronounced brain involvement in fatal COVID-19 outcomes Purification and Characterization of 1008 Progenitor and Mature Human Astrocytes Reveals Transcriptional and Functional Differences 1009 with Mouse SUPPLEMENTARY FIGURE LEGENDS Supplementary figure 1 related to Figure 1: Immunohistochemistry for microglial markers and Bielschowsky stain indicates microgliosis, microglial nodules and neuronal injury TMEM119 (brown) and CD68 (brown) is shown. The samples were counterstained with Haematoxylin (blue) B: Bielschowsky stain. A representative image showing a loss of continuous black staining at a site of myeloid accumulation, indicating axonal rarefication (asterisks). The scale bar represents 100 µm and 20 µm in the insert D: Cell-type-specific RNA expression levels of genes encoding for proteins depicted in Figure 2C were extracted from www.brainrnaseq.org and visualized across populations of astrocytes, neurons, microglia/macrophages, oligodendrocytes and endothelial cells (Zhang et al., 2016) . Figure 3 : Cellular neighborhood analysis and mass cytometry profiling reveal context-specific T cell interaction partners as well as differential activation and exhaustion signatures. A: Heatmap depicting results of the neighborhood analysis in control patients similar to the analysis in COVID-19 patients described in Figure 3B . The cluster order on both axis was chosen according to Figure 3B to facilitate comparison. B: Cluster c19 spatial neighborhood interactions were determined in COVID-19 and control patients. Rows indicate significant enrichment or depletion of cells from clusters c1 -c34 in the vicinity of c19 cells.C: Cluster c19 cells were analyzed for expression of immune markers involved in T-cell activation, differentiation, exhaustion and function. Frequency of positive cells is shown as boxplots with median, IQR and upper and lower whiskers and compared between patient groups. J o u r n a l P r e -p r o o f D: CD8 T cells isolated from the medulla, olfactory bulb, cortex and regional lymph node of a deceased COVID-19 patient were analyzed by suspension mode mass cytometry as in Fig. 3F . CD8 T cells are visualized on a tSNE map. The expression of several exhaustion markers is indicated by heatmap coloring.Significant differences were determined by unpaired t tests with Welch's correction in C. The t-SNE visualization of the brain immune landscape as in Figure 2D is shown for individual patients. Brain immune maps are shown from the (A) medulla and (B) olfactory bulb of COVID-19 patients, and the medulla of (C) control patients, (D) ECMO patients and (E) Multiple Sclerosis patients. Each dot represents a cell. The coloring refers to the respective immune cell cluster as indicated.